Rossby Financial LCC Makes New $336,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Rossby Financial LCC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,026 shares of the company’s stock, valued at approximately $336,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Atwood & Palmer Inc. bought a new stake in HCA Healthcare during the first quarter worth about $28,000. Bartlett & CO. Wealth Management LLC boosted its position in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock worth $31,000 after acquiring an additional 80 shares in the last quarter. Tidemark LLC acquired a new position in HCA Healthcare during the fourth quarter valued at approximately $36,000. ORG Partners LLC increased its stake in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company’s stock valued at $38,000 after purchasing an additional 86 shares during the last quarter. Finally, Legacy Investment Solutions LLC lifted its position in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock worth $62,000 after buying an additional 95 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Down 2.9%

Shares of HCA Healthcare stock opened at $378.33 on Thursday. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The stock has a fifty day simple moving average of $370.01 and a 200 day simple moving average of $338.21. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market capitalization of $91.01 billion, a P/E ratio of 16.82, a price-to-earnings-growth ratio of 1.34 and a beta of 1.47.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.36 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.76%. HCA Healthcare’s payout ratio is currently 12.81%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Wells Fargo & Company upgraded shares of HCA Healthcare from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Barclays set a $416.00 price target on HCA Healthcare and gave the company an “overweight” rating in a research note on Monday, June 2nd. Robert W. Baird reissued a “neutral” rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Baird R W lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Eight analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $395.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.